ARCHIVES

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Kathy Giusti Named One of The TIME’s 100 Most Influential People

April 22, 2011

UICC Seeks Nominations for Mucio Athayde Prize.

January 7, 2000

14th Cancer Congress Big Success; CICA Satellite Established; US, USSR Renew Cancer Agreement

September 12, 1986

Cancer Act Doesn’t Require Geographic Distribution Of Comp Centers

March 4, 1977

Also in this 8-page issue: House Committee on Energy and Commerce is investigating the collapse of the Institute for Cancer Prevention, which owes $5.7 million to NCI.

December 3, 2004

DCT Board Approves Concept Of Planning Grants For New Particle Therapy Equipment Development

August 7, 1981